APO Research
Talk to an analyst

APO RESEARCH · REPORT

Herpes Simplex Virus (HSV) Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Herpes Simplex Virus (HSV) Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025173 pages

Choose your research edition.

Industry ResearchHerpes Simplex Virus (HSV) Vaccines Industry Research Report 2026112 pages · $2,950 USDIndustry Growth & TrendsGlobal Herpes Simplex Virus (HSV) Vaccines Industry Growth and Trends Forecast to 203272 pages · $3,450 USDMarket StructureGlobal Herpes Simplex Virus (HSV) Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032173 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Herpes Simplex Virus (HSV) Vaccines Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Herpes Simplex Virus (HSV) Vaccines Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Herpes Simplex Virus (HSV) Vaccines market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Herpes Simplex Virus (HSV) Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Herpes Simplex Virus (HSV) Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Herpes Simplex Virus (HSV) Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Herpes Simplex Virus (HSV) Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Herpes Simplex Virus (HSV) Vaccines include Sanofi, GlaxoSmithKline, Vical and Genocea Biosciences, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Herpes Simplex Virus (HSV) Vaccines market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Herpes Simplex Virus (HSV) Vaccines and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Herpes Simplex Virus (HSV) Vaccines sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Herpes Simplex Virus (HSV) Vaccines market size, projected growth trends, production technologies, key applications, and end-use industries.

Herpes Simplex Virus (HSV) Vaccines Segment by Company

Sanofi

GlaxoSmithKline

Vical

Genocea Biosciences

Herpes Simplex Virus (HSV) Vaccines Segment by Type

VCL-HB01

HSV529

GEN-003

Others

Herpes Simplex Virus (HSV) Vaccines Segment by Application

HSV-1 (Oral Herpes)

HSV-2 (Genital Herpes)

Herpes Simplex Virus (HSV) Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Herpes Simplex Virus (HSV) Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Herpes Simplex Virus (HSV) Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Herpes Simplex Virus (HSV) Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Herpes Simplex Virus (HSV) Vaccines market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Herpes Simplex Virus (HSV) Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Herpes Simplex Virus (HSV) Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Herpes Simplex Virus (HSV) Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Herpes Simplex Virus (HSV) Vaccines Industry Trends Table 2. Herpes Simplex Virus (HSV) Vaccines Industry Drivers Table 3. Herpes Simplex Virus (HSV) Vaccines Industry Opportunities and Challenges Table 4. Herpes Simplex Virus (HSV) Vaccines Industry Restraints Table 5. Global Herpes Simplex Virus (HSV) Vaccines Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Herpes Simplex Virus (HSV) Vaccines Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Manufacturers Table 9. Global Herpes Simplex Virus (HSV) Vaccines Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Herpes Simplex Virus (HSV) Vaccines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Herpes Simplex Virus (HSV) Vaccines Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Herpes Simplex Virus (HSV) Vaccines Manufacturers, Product Type & Application Table 13. Global Herpes Simplex Virus (HSV) Vaccines Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Herpes Simplex Virus (HSV) Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of VCL-HB01 Table 17. Major Manufacturers of HSV529 Table 18. Major Manufacturers of GEN-003 Table 19. Major Manufacturers of Others Table 20. Global Herpes Simplex Virus (HSV) Vaccines Sales by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Herpes Simplex Virus (HSV) Vaccines Sales by Type (2021-2026) & (k units) Table 22. Global Herpes Simplex Virus (HSV) Vaccines Sales by Type (2027-2032) & (k units) Table 23. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2021-2026) Table 24. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2027-2032) Table 25. Global Herpes Simplex Virus (HSV) Vaccines Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 26. Global Herpes Simplex Virus (HSV) Vaccines Revenue by Type (2021-2026) & (k units) Table 27. Global Herpes Simplex Virus (HSV) Vaccines Revenue by Type (2027-2032) & (k units) Table 28. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Type (2021-2026) Table 29. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of HSV-1 (Oral Herpes) Table 31. Major Manufacturers of HSV-2 (Genital Herpes) Table 32. Global Herpes Simplex Virus (HSV) Vaccines Sales by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Herpes Simplex Virus (HSV) Vaccines Sales by Application (2021-2026) & (k units) Table 34. Global Herpes Simplex Virus (HSV) Vaccines Sales by Application (2027-2032) & (k units) Table 35. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application (2021-2026) Table 36. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application (2027-2032) Table 37. Global Herpes Simplex Virus (HSV) Vaccines Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 38. Global Herpes Simplex Virus (HSV) Vaccines Revenue by Application (2021-2026) & (k units) Table 39. Global Herpes Simplex Virus (HSV) Vaccines Revenue by Application (2027-2032) & (k units) Table 40. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Application (2021-2026) Table 41. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Application (2027-2032) Table 42. Global Herpes Simplex Virus (HSV) Vaccines Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Herpes Simplex Virus (HSV) Vaccines Sales by Region (2021-2026) & (k units) Table 44. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Region (2021-2026) Table 45. Global Herpes Simplex Virus (HSV) Vaccines Sales Forecasted by Region (2027-2032) & (k units) Table 46. Global Herpes Simplex Virus (HSV) Vaccines Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Herpes Simplex Virus (HSV) Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 48. North America Herpes Simplex Virus (HSV) Vaccines Sales by Country (2021-2026) & (k units) Table 49. North America Herpes Simplex Virus (HSV) Vaccines Sales by Country (2027-2032) & (k units) Table 50. Europe Herpes Simplex Virus (HSV) Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 51. Europe Herpes Simplex Virus (HSV) Vaccines Sales by Country (2021-2026) & (k units) Table 52. Europe Herpes Simplex Virus (HSV) Vaccines Sales by Country (2027-2032) & (k units) Table 53. Asia Pacific Herpes Simplex Virus (HSV) Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Asia Pacific Herpes Simplex Virus (HSV) Vaccines Sales by Country (2021-2026) & (k units) Table 55. Asia Pacific Herpes Simplex Virus (HSV) Vaccines Sales by Country (2027-2032) & (k units) Table 56. South America, Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 57. South America, Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Sales by Country (2021-2026) & (k units) Table 58. South America, Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Sales by Country (2027-2032) & (k units) Table 59. Global Herpes Simplex Virus (HSV) Vaccines Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Herpes Simplex Virus (HSV) Vaccines Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Herpes Simplex Virus (HSV) Vaccines Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Region (2021-2026) Table 63. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Region (2027-2032) Table 64. Sanofi Company Information Table 65. Sanofi Business Overview Table 66. Sanofi Herpes Simplex Virus (HSV) Vaccines Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Sanofi Herpes Simplex Virus (HSV) Vaccines Product Portfolio Table 68. Sanofi Recent Development Table 69. GlaxoSmithKline Company Information Table 70. GlaxoSmithKline Business Overview Table 71. GlaxoSmithKline Herpes Simplex Virus (HSV) Vaccines Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. GlaxoSmithKline Herpes Simplex Virus (HSV) Vaccines Product Portfolio Table 73. GlaxoSmithKline Recent Development Table 74. Vical Company Information Table 75. Vical Business Overview Table 76. Vical Herpes Simplex Virus (HSV) Vaccines Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Vical Herpes Simplex Virus (HSV) Vaccines Product Portfolio Table 78. Vical Recent Development Table 79. Genocea Biosciences Company Information Table 80. Genocea Biosciences Business Overview Table 81. Genocea Biosciences Herpes Simplex Virus (HSV) Vaccines Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Genocea Biosciences Herpes Simplex Virus (HSV) Vaccines Product Portfolio Table 83. Genocea Biosciences Recent Development Table 84. Key Raw Materials Table 85. Raw Materials Key Suppliers Table 86. Herpes Simplex Virus (HSV) Vaccines Distributors List Table 87. Herpes Simplex Virus (HSV) Vaccines Customers List Table 88. Research Programs/Design for This Report Table 89. Authors List of This Report Table 90. Secondary Sources Table 91. Primary Sources List of Figures Figure 1. Herpes Simplex Virus (HSV) Vaccines Product Image Figure 2. Global Herpes Simplex Virus (HSV) Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Herpes Simplex Virus (HSV) Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global Herpes Simplex Virus (HSV) Vaccines Sales (2021-2032) & (k units) Figure 5. Global Herpes Simplex Virus (HSV) Vaccines Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Herpes Simplex Virus (HSV) Vaccines Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. VCL-HB01 Image Figure 9. HSV529 Image Figure 10. GEN-003 Image Figure 11. Others Image Figure 12. Global Herpes Simplex Virus (HSV) Vaccines Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2021-2032) Figure 15. Global Herpes Simplex Virus (HSV) Vaccines Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 16. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Type (2021-2032) Figure 18. HSV-1 (Oral Herpes) Image Figure 19. HSV-2 (Genital Herpes) Image Figure 20. Global Herpes Simplex Virus (HSV) Vaccines Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application (2021-2032) Figure 23. Global Herpes Simplex Virus (HSV) Vaccines Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Application (2021-2032) Figure 26. North America Herpes Simplex Virus (HSV) Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 27. North America Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Country (2021-2032) Figure 28. U.S. Herpes Simplex Virus (HSV) Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 29. Canada Herpes Simplex Virus (HSV) Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 30. Mexico Herpes Simplex Virus (HSV) Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Herpes Simplex Virus (HSV) Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 32. Europe Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Country (2021-2032) Figure 33. Germany Herpes Simplex Virus (HSV) Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 34. France Herpes Simplex Virus (HSV) Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 35. U.K. Herpes Simplex Virus (HSV) Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 36. Italy Herpes Simplex Virus (HSV) Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 37. Netherlands Herpes Simplex Virus (HSV) Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Herpes Simplex Virus (HSV) Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 39. Asia Pacific Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Country (2021-2032) Figure 40. China Herpes Simplex Virus (HSV) Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 41. Japan Herpes Simplex Virus (HSV) Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 42. South Korea Herpes Simplex Virus (HSV) Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 43. Southeast Asia Herpes Simplex Virus (HSV) Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 44. India Herpes Simplex Virus (HSV) Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 45. Australia Herpes Simplex Virus (HSV) Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 47. South America, Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Country (2021-2032) Figure 48. Brazil Herpes Simplex Virus (HSV) Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 49. South Africa Herpes Simplex Virus (HSV) Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 50. Saudi Arabia Herpes Simplex Virus (HSV) Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 51. Turkey Herpes Simplex Virus (HSV) Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 52. Argentina Herpes Simplex Virus (HSV) Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 53. UAE Herpes Simplex Virus (HSV) Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 54. Egypt Herpes Simplex Virus (HSV) Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 55. Chile Herpes Simplex Virus (HSV) Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 56. Global Herpes Simplex Virus (HSV) Vaccines Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Herpes Simplex Virus (HSV) Vaccines Revenue (2021-2032) & (US$ Million) Figure 59. North America Herpes Simplex Virus (HSV) Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Herpes Simplex Virus (HSV) Vaccines Revenue (2021-2032) & (US$ Million) Figure 61. Europe Herpes Simplex Virus (HSV) Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Herpes Simplex Virus (HSV) Vaccines Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Herpes Simplex Virus (HSV) Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Herpes Simplex Virus (HSV) Vaccines Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Herpes Simplex Virus (HSV) Vaccines Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • VCL-HB01
  • HSV529
  • GEN-003
  • Others
Applications
  • HSV-1 (Oral Herpes)
  • HSV-2 (Genital Herpes)
Companies covered
  • Sanofi
  • GlaxoSmithKline
  • Vical
  • Genocea Biosciences

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Herpes Simplex Virus (HSV) Vaccines Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Herpes Simplex Virus (HSV) Vaccines Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Herpes Simplex Virus (HSV) Vaccines Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Herpes Simplex Virus (HSV) Vaccines Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Herpes Simplex Virus (HSV) Vaccines Market Dynamics
  1. 2.1 Herpes Simplex Virus (HSV) Vaccines Industry Trends
  2. 2.2 Herpes Simplex Virus (HSV) Vaccines Industry Drivers
  3. 2.3 Herpes Simplex Virus (HSV) Vaccines Industry Opportunities and Challenges
  4. 2.4 Herpes Simplex Virus (HSV) Vaccines Industry Restraints
3 Herpes Simplex Virus (HSV) Vaccines Market by Manufacturers
  1. 3.1 Global Herpes Simplex Virus (HSV) Vaccines Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Herpes Simplex Virus (HSV) Vaccines Sales by Manufacturers (2021-2026)
  3. 3.3 Global Herpes Simplex Virus (HSV) Vaccines Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Herpes Simplex Virus (HSV) Vaccines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Herpes Simplex Virus (HSV) Vaccines Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Herpes Simplex Virus (HSV) Vaccines Manufacturers, Product Type & Application
  7. 3.7 Global Herpes Simplex Virus (HSV) Vaccines Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Herpes Simplex Virus (HSV) Vaccines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Herpes Simplex Virus (HSV) Vaccines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Herpes Simplex Virus (HSV) Vaccines Tier 1, Tier 2, and Tier 3
4 Herpes Simplex Virus (HSV) Vaccines Market by Type
  1. 4.1 Herpes Simplex Virus (HSV) Vaccines Type Introduction
  2. 4.1.1 VCL-HB01
  3. 4.1.2 HSV529
  4. 4.1.3 GEN-003
  5. 4.1.4 Others
  6. 4.2 Global Herpes Simplex Virus (HSV) Vaccines Sales by Type
  7. 4.2.1 Global Herpes Simplex Virus (HSV) Vaccines Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Herpes Simplex Virus (HSV) Vaccines Sales by Type (2021-2032)
  9. 4.2.3 Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2021-2032)
  10. 4.3 Global Herpes Simplex Virus (HSV) Vaccines Revenue by Type
  11. 4.3.1 Global Herpes Simplex Virus (HSV) Vaccines Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Herpes Simplex Virus (HSV) Vaccines Revenue by Type (2021-2032)
  13. 4.3.3 Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Type (2021-2032)
5 Herpes Simplex Virus (HSV) Vaccines Market by Application
  1. 5.1 Herpes Simplex Virus (HSV) Vaccines Application Introduction
  2. 5.1.1 HSV-1 (Oral Herpes)
  3. 5.1.2 HSV-2 (Genital Herpes)
  4. 5.2 Global Herpes Simplex Virus (HSV) Vaccines Sales by Application
  5. 5.2.1 Global Herpes Simplex Virus (HSV) Vaccines Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Herpes Simplex Virus (HSV) Vaccines Sales by Application (2021-2032)
  7. 5.2.3 Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application (2021-2032)
  8. 5.3 Global Herpes Simplex Virus (HSV) Vaccines Revenue by Application
  9. 5.3.1 Global Herpes Simplex Virus (HSV) Vaccines Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Herpes Simplex Virus (HSV) Vaccines Revenue by Application (2021-2032)
  11. 5.3.3 Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Application (2021-2032)
6 Global Herpes Simplex Virus (HSV) Vaccines Sales by Region
  1. 6.1 Global Herpes Simplex Virus (HSV) Vaccines Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Herpes Simplex Virus (HSV) Vaccines Sales by Region (2021-2032)
  3. 6.2.1 Global Herpes Simplex Virus (HSV) Vaccines Sales by Region (2021-2026)
  4. 6.2.2 Global Herpes Simplex Virus (HSV) Vaccines Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Herpes Simplex Virus (HSV) Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Herpes Simplex Virus (HSV) Vaccines Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Herpes Simplex Virus (HSV) Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Herpes Simplex Virus (HSV) Vaccines Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Herpes Simplex Virus (HSV) Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Herpes Simplex Virus (HSV) Vaccines Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Herpes Simplex Virus (HSV) Vaccines Revenue by Region
  1. 7.1 Global Herpes Simplex Virus (HSV) Vaccines Revenue by Region
  2. 7.1.1 Global Herpes Simplex Virus (HSV) Vaccines Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Herpes Simplex Virus (HSV) Vaccines Revenue by Region (2021-2026)
  4. 7.1.3 Global Herpes Simplex Virus (HSV) Vaccines Revenue by Region (2027-2032)
  5. 7.1.4 Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Herpes Simplex Virus (HSV) Vaccines Revenue (2021-2032)
  8. 7.2.2 North America Herpes Simplex Virus (HSV) Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Herpes Simplex Virus (HSV) Vaccines Revenue (2021-2032)
  11. 7.3.2 Europe Herpes Simplex Virus (HSV) Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Herpes Simplex Virus (HSV) Vaccines Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Herpes Simplex Virus (HSV) Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Sanofi
  2. 8.1.1 Sanofi Company Information
  3. 8.1.2 Sanofi Business Overview
  4. 8.1.3 Sanofi Herpes Simplex Virus (HSV) Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Sanofi Herpes Simplex Virus (HSV) Vaccines Product Portfolio
  6. 8.1.5 Sanofi Recent Developments
  7. 8.2 GlaxoSmithKline
  8. 8.2.1 GlaxoSmithKline Company Information
  9. 8.2.2 GlaxoSmithKline Business Overview
  10. 8.2.3 GlaxoSmithKline Herpes Simplex Virus (HSV) Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 GlaxoSmithKline Herpes Simplex Virus (HSV) Vaccines Product Portfolio
  12. 8.2.5 GlaxoSmithKline Recent Developments
  13. 8.3 Vical
  14. 8.3.1 Vical Company Information
  15. 8.3.2 Vical Business Overview
  16. 8.3.3 Vical Herpes Simplex Virus (HSV) Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Vical Herpes Simplex Virus (HSV) Vaccines Product Portfolio
  18. 8.3.5 Vical Recent Developments
  19. 8.4 Genocea Biosciences
  20. 8.4.1 Genocea Biosciences Company Information
  21. 8.4.2 Genocea Biosciences Business Overview
  22. 8.4.3 Genocea Biosciences Herpes Simplex Virus (HSV) Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Genocea Biosciences Herpes Simplex Virus (HSV) Vaccines Product Portfolio
  24. 8.4.5 Genocea Biosciences Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Herpes Simplex Virus (HSV) Vaccines Value Chain Analysis
  2. 9.1.1 Herpes Simplex Virus (HSV) Vaccines Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Herpes Simplex Virus (HSV) Vaccines Production Mode & Process
  6. 9.2 Herpes Simplex Virus (HSV) Vaccines Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Herpes Simplex Virus (HSV) Vaccines Distributors
  9. 9.2.3 Herpes Simplex Virus (HSV) Vaccines Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst